Abstract
Protein phosphatase 2A (PP2A) is a family of heterotrimeric protein phosphatases that has a multitude of functions inside the cell, acting through various substrate targets in cell-signaling pathways. Recent evidence suggests that a subset of PP2A holoenzymes function as tumor suppressors and one particular family of B subunits, B56, are implicated in this function. However, the regulatory mechanisms that govern activation of B56–PP2A tumor-suppressive function have not been elucidated. In the present study, we demonstrate that ataxia-telangiectasia mutated (ATM) directly phosphorylates and specifically regulates B56γ3, B56γ2 and B56δ, after DNA damage. We further show that phosphorylation of B56γ3 at Ser510 leads to an increase in B56γ3–PP2A complexes, and direction of PP2A phosphatase activity toward the substrate p53, activating its tumor-suppressive functions. In addition, we found that under cell growth conditions B56γ3 is kept at low levels through the actions of the E3 ubiquitin ligase MDM2, and, importantly, phosphorylation of B56γ3 by ATM leads to upregulation of the protein by blocking MDM2-mediated B56γ3 ubiquitination. Finally, we show that Ser510 phosphorylation significantly enhances the ability of B56γ3 to inhibit cell proliferation and anchorage-independent growth. These results provide mechanistic insight into the regulation of PP2A tumor-suppressive function, and suggest a model for parallel regulation of p53 and B56γ3.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ahn J-H, McAvoy T, Rakhilin SV, Nishi A, Greengard P, Nairn AC . (2007). Protein kinase A activates protein phosphatase 2A by phosphorylation of the B56δ subunit. Proc Natl Acad Sci USA 104: 2979–2984.
Arnold HK, Sears RC . (2006). Protein phosphatase 2A regulatory subunit B56α associates with c-Myc and negatively regulates c-Myc accumulation. Mol Cell Biol 26: 2832–2844.
Canman CE, Lim D-S, Cimprich KA, Taya Y, Tamai K, Sakaguchi K et al. (1998). Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 281: 1677–1679.
Eichorn PJA, Creyghton MP, Bernards R . (2009). Protein phosphatase 2A regulatory subunits and cancer. Biochim Biophys Acta 1795: 1–15.
Hickson I, Zhao Y, Richardson CJ, Green SJ, Martin NMB, Orr AI et al. (2004). Identification and characterization of a novel specific inhibitor of the Ataxia-Telangiectasia Mutated kinase ATM. Cancer Res 64: 9152–9159.
Janssens V, Longin S, Goris J . (2008). PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). Trends Biochem Sci 33: 113–121.
Kim ST, Lim DS, Canman CE, Kastan MB . (1999). Substrate specificities and identification of putative substrates of ATM kinase family members. J Biol Chem 274: 37538–37543.
Li H-H, Cai X, Shouse GP, Piluso LG, Liu X . (2007). A specific PP2A regulatory subunit, B56γ, mediates DNA damage-induced dephosphorylation of p53 at Thr55. EMBO 26: 402–411.
Lim D-S, Kim S-T, Xu B, Maser RS, Lin J, Petrini JHJ et al. (2000). ATM phosphorylates p95/nbs1 in a S-phase checkpoint pathway. Nature 404: 613–617.
Margolis SS, Perry JA, Forester CM, Nutt LK, Guo MJ, Jardim MJ et al. (2006). Role for the PP2A/B56δ phosphatase in regulating 14-3-3 release from Cdc25 to control mitosis. Cell 127: 759–763.
Mumby M . (2007). PP2A: unveiling a reluctant tumor suppressor. Cell 130: 21–24.
Muneer S, Ramalingam V, Wyatt R, Schultz RA, Minna JD, Kamibayashi C . (2002). Genomic organization and mapping of the gene encoding the PP2A B56gamma regulatory subunit. Genomics 79: 344–348.
Nousiainen M, Sillje HHW, Sauer G, Nigg EA, Korner R . (2006). Phosphoproteome analysis of the human mitotic spindle. Proc Natl Acad Sci USA 103: 5391–5396.
Okamoto K, Li H, Jensen MR, Zhang T, Tava Y, Thorgeirsson SS et al. (2002). Cyclin G recruits PP2A to dephosphorylate MDM2. Mol Cell 9: 761–771.
O'Neill T, Dwyer AJ, Ziv Y, Chan DW, Lees-Miller SP . (2000). Utilization of oriented peptide libraries to identify substrate motifs selected by ATM. J Biol Chem 275: 22719–22727.
Ortega-Lazaro JC, del Mazo J . (2003). Expression of the B56delta subunit of protein phosphatase 2A and Mea1 in mouse spermatogenesis: identification of a new B56gamma subunit (B56gamma4) specifically expressed in testis. Cytogenet Genome Res 103: 345–351.
Shouse GP, Cai X, Liu X . (2008). Serine 15 phosphorylation of p53 directs its interaction with B56γ and the tumor suppressor activity of B56γ-specific protein phosphatase 2A. Mol Cell Biol 28: 448–456.
Shouse GP, Nobumori Y, Liu X . (2010). A B56γ mutation in lung cancer disrupts the p53-dependent tumor suppressor function of protein phosphatase 2A. Oncogene 29: 3933–3941.
Silverstein AM, Barrow CA, Davis AJ, Mumby MC . (2002). Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits. Proc Natl Acad Sci USA 99: 4221–4226.
Sontag E . (2001). Protein phosphatase 2A: the Trojan horse of cellular signaling. Cell Signal 13: 7–16.
Strack S, Ruediger R, Walter G, Dagda RK, Barwacz CA, Cribbs JT . (2002). Protein phosphatase 2A holoenzyme assembly, identification of contacts between b-family regulatory and scaffolding A subunits. J Biol Chem 277: 20750–20755.
Virshup D, Shenolikar S . (2009). From promiscuity to precision: protein phosphatases get a makeover. Mol Cell 33: 537–545.
Westermarck J, Hahn WC . (2008). Multiple pathways regulated by the tumor suppressor PP2A in transformation. Trends Mol Med 14: 152–160.
Yeh E, Cunningham M, Arnold H, Chasse D, Monteith T, Ivaldi G et al. (2004). A signaling pathway controlling c-Myc degradation that impacts oncogenic transformation of human cells. Nat Cell Biol 6: 308–318.
Acknowledgements
We are very grateful to Dr D Virshup for providing B56δ antibody, to Dr M Kastan for providing ATM plasmids, to Dr J Momand for providing SJSA-1 cells, and to Dr G Smith and Kudos Pharmaceuticals for providing the ATM inhibitor KU55933. We thank Drs E Lee, D Virshup, JA Traugh, and all members of our laboratory for the many helpful discussions. This work was supported by NIH grant CA075180 from the National Institute of Cancer.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Oncogene website
Supplementary information
Rights and permissions
About this article
Cite this article
Shouse, G., Nobumori, Y., Panowicz, M. et al. ATM-mediated phosphorylation activates the tumor-suppressive function of B56γ–PP2A. Oncogene 30, 3755–3765 (2011). https://doi.org/10.1038/onc.2011.95
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/onc.2011.95
Keywords
This article is cited by
-
The repression of oncoprotein SET by the tumor suppressor p53 reveals a p53-SET-PP2A feedback loop for cancer therapy
Science China Life Sciences (2023)
-
The B56γ3-containing protein phosphatase 2A attenuates p70S6K-mediated negative feedback loop to enhance AKT-facilitated epithelial-mesenchymal transition in colorectal cancer
Cell Communication and Signaling (2023)
-
Prognostic Impact of PPP2R5C Gene Expression in Adult Acute Myeloid Leukemia Patients with Normal Cytogenetics
Indian Journal of Hematology and Blood Transfusion (2020)
-
ER stress regulating protein phosphatase 2A-B56γ, targeted by hepatitis B virus X protein, induces cell cycle arrest and apoptosis of hepatocytes
Cell Death & Disease (2018)
-
Transient PP2A inhibition alleviates normal tissue stem cell susceptibility to cell death during radiotherapy
Cell Death & Disease (2018)